Absci Corp (ABSI)
4.62
-0.12
(-2.53%)
USD |
NASDAQ |
May 17, 16:00
4.62
0.00 (0.00%)
After-Hours: 20:00
Absci Free Cash Flow (Quarterly): -17.86M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -17.86M |
| December 31, 2023 | -14.94M |
| September 30, 2023 | -10.67M |
| June 30, 2023 | -19.49M |
| March 31, 2023 | -20.40M |
| December 31, 2022 | -19.13M |
| September 30, 2022 | -23.91M |
| June 30, 2022 | -26.47M |
| March 31, 2022 | -28.01M |
| Date | Value |
|---|---|
| December 31, 2021 | -25.40M |
| September 30, 2021 | -27.37M |
| June 30, 2021 | -32.23M |
| March 31, 2021 | -13.65M |
| December 31, 2020 | -3.441M |
| September 30, 2020 | -3.443M |
| June 30, 2020 | -3.649M |
| March 31, 2020 | -2.618M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-32.23M
Minimum
Jun 2021
-2.618M
Maximum
Mar 2020
-17.22M
Average
-19.13M
Median
Dec 2022
Free Cash Flow (Quarterly) Benchmarks
| Eli Lilly and Co | 83.20M |
| Recursion Pharmaceuticals Inc | -108.95M |
| Creative Medical Technology Holdings Inc | -0.8969M |
| CytomX Therapeutics Inc | -26.16M |
| HOOKIPA Pharma Inc | -24.27M |